{"id":"eye-drops-tropicamid","safety":{"commonSideEffects":[{"rate":null,"effect":"Transient stinging or irritation"},{"rate":null,"effect":"Blurred vision"},{"rate":null,"effect":"Photophobia"},{"rate":null,"effect":"Increased intraocular pressure (in susceptible patients)"},{"rate":null,"effect":"Systemic anticholinergic effects (rare with topical use)"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Tropicamide competitively antagonizes acetylcholine at muscarinic receptors on the iris sphincter muscle and ciliary muscle. This causes mydriasis (pupil dilation) and cycloplegia (paralysis of accommodation), allowing clear visualization of the retina during ophthalmologic examination. The effect is temporary and reversible.","oneSentence":"Tropicamide is an anticholinergic agent that blocks muscarinic acetylcholine receptors in the eye to dilate the pupil and paralyze accommodation.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:46:10.729Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Mydriasis and cycloplegia for diagnostic ophthalmologic examination"},{"name":"Pupil dilation for fundoscopic examination"}]},"trialDetails":[{"nctId":"NCT07495670","phase":"NA","title":"Comparison of 4 Methods of Eye Drops for Pupil Dilation in Diabetic Patients","status":"COMPLETED","sponsor":"Burapha University","startDate":"2024-11-04","conditions":"Diabetes (DM), Retinopathy, Diabetic, Pupil Dilation","enrollment":84},{"nctId":"NCT07419776","phase":"","title":"The Effect Of Polycystic Ovarian Syndrome Treatment On Ocular Surface.","status":"COMPLETED","sponsor":"Cairo University","startDate":"2023-06-24","conditions":"Poly Cystic Ovary Syndrome","enrollment":90},{"nctId":"NCT00227253","phase":"","title":"Chromosome 18 Clinical Research Center","status":"RECRUITING","sponsor":"The University of Texas Health Science Center at San Antonio","startDate":"1993-09","conditions":"Chromosome Aberrations, Growth Hormone Deficiency, Hypomyelination","enrollment":4000},{"nctId":"NCT04712747","phase":"","title":"Adaptive Optics (AO) Analysis of Retinal Arteries in Patients With Recent Stroke (STROKAO)","status":"COMPLETED","sponsor":"Fondation Ophtalmologique Adolphe de Rothschild","startDate":"2021-01-25","conditions":"Stroke","enrollment":91},{"nctId":"NCT07088705","phase":"NA","title":"Subthreshold Micropulse Laser Therapy (SML) in Retinitis Pigmentosa","status":"ENROLLING_BY_INVITATION","sponsor":"Marta P. Wiącek","startDate":"2024-09-01","conditions":"Retinitis Pigmentosa (RP)","enrollment":60},{"nctId":"NCT07075224","phase":"PHASE1, PHASE2","title":"Pharmacodynamics of a Fixed Dose Combination of 0.34% Tropicamide and 2.5% Phenylephrine Hydrochloride, Eye Drop, Solution","status":"NOT_YET_RECRUITING","sponsor":"Unither Pharmaceuticals, France","startDate":"2025-07-15","conditions":"Mydriasis","enrollment":20},{"nctId":"NCT06161636","phase":"","title":"Contribution of the Kinematic Theory in the Early Differential Diagnosis of the Parkinson's Disease","status":"RECRUITING","sponsor":"Centre hospitalier de l'Université de Montréal (CHUM)","startDate":"2020-02-19","conditions":"Parkinson Disease, Healthy, Parkinsonian Syndromes","enrollment":90},{"nctId":"NCT04907474","phase":"PHASE4","title":"Evaluation of Pupil Dilation Speed With the MAP Dispenser","status":"COMPLETED","sponsor":"Eyenovia Inc.","startDate":"2021-05-24","conditions":"Mydriasis","enrollment":61},{"nctId":"NCT06649513","phase":"","title":"Long-term Ophthalmic Outcomes in Ex-premature Infants","status":"NOT_YET_RECRUITING","sponsor":"Erasmus Medical Center","startDate":"2024-11-01","conditions":"Retinopathy of Prematurity (ROP), Premature Birth","enrollment":210},{"nctId":"NCT02023086","phase":"","title":"Clinical Investigation on the Blood Oxygenation at the Optic Nerve Head in Fabry Patients","status":"COMPLETED","sponsor":"Université de Montréal","startDate":"2014-08","conditions":"Fabry Disease","enrollment":8},{"nctId":"NCT06213896","phase":"","title":"Detecting Eye Diseases Via Hybrid Deep Learning Algorithms From Fundus Images","status":"COMPLETED","sponsor":"Ural Telekomunikasyon Sanayi Ticaret Anonim Sirketi","startDate":"2023-03-01","conditions":"Glaucoma, Age-Related Macular Degeneration, Retinal Vein Occlusion","enrollment":1528},{"nctId":"NCT06217796","phase":"PHASE4","title":"Safety and Efficacy of Fixed Combination Phenylephrine-Tropicamide for Pupil Dilation","status":"COMPLETED","sponsor":"Eyenovia Inc.","startDate":"2023-11-28","conditions":"Mydriasis","enrollment":30},{"nctId":"NCT06288321","phase":"EARLY_PHASE1","title":"A Study Investigating Whether Low Dose Eyedrops for Pupil Dilation is as Effective and Safe as Standard Dose Eyedrops in Examination for Retinopathy of Prematurity.","status":"COMPLETED","sponsor":"The University of Hong Kong","startDate":"2022-08-10","conditions":"Retinopathy of Prematurity","enrollment":18},{"nctId":"NCT03959176","phase":"PHASE4","title":"The Effect of Brimonidine","status":"COMPLETED","sponsor":"Wake Forest University Health Sciences","startDate":"2019-07-20","conditions":"Intraocular Pressure","enrollment":13},{"nctId":"NCT06077682","phase":"PHASE4","title":"Cycloplegic Refraction in Pediatric Patients With Esotropia","status":"UNKNOWN","sponsor":"Islamic Hospital, Jordan","startDate":"2023-09-01","conditions":"Cycloplegia, Refractive Errors, Esotropia","enrollment":100},{"nctId":"NCT05223478","phase":"PHASE3","title":"Nyxol (0.75% Phentolamine Ophthalmic Solution) to Reverse Pharmacologically-Induced Mydriasis in Pediatric Subjects","status":"COMPLETED","sponsor":"Ocuphire Pharma, Inc.","startDate":"2021-12-17","conditions":"Mydriasis, Dilation","enrollment":23},{"nctId":"NCT05925894","phase":"NA","title":"Efficacy Mydrane ® for Cataract Surgery in Patients With Concomitant Primary Open Angle Glaucoma.","status":"COMPLETED","sponsor":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","startDate":"2021-03-18","conditions":"Cataract Surgery","enrollment":60},{"nctId":"NCT05880433","phase":"","title":"The Effects of Mydriatic Eye Drops in Retinopathy of Prematurity Examinations","status":"COMPLETED","sponsor":"Istanbul Training and Research Hospital","startDate":"2021-05-01","conditions":"Retinopathy of Prematurity, Mydriasis, Neonatal Disease","enrollment":62},{"nctId":"NCT05771194","phase":"PHASE4","title":"Analysis of Postoperative Ocular Surface Changes and Intervention Effect After PPV in MGD Dry Eye Patients","status":"COMPLETED","sponsor":"Tianjin Medical University Eye Hospital","startDate":"2021-02-01","conditions":"Meibomian Gland Dysfunction of Unspecified Eye, Unspecified Eyelid","enrollment":40},{"nctId":"NCT05238233","phase":"PHASE4","title":"Wearing-Off Period of Pharmacological Dilation and Anisocoria","status":"COMPLETED","sponsor":"Prisma Health-Upstate","startDate":"2022-04-01","conditions":"Anisocoria","enrollment":11},{"nctId":"NCT05449015","phase":"PHASE4","title":"Study on the Effect of Two Ways of Cycloplegia on Biological Parameters of Ciliary Muscle","status":"UNKNOWN","sponsor":"Shanghai Eye Disease Prevention and Treatment Center","startDate":"2020-12-22","conditions":"Accomodation, Refractive Errors, Myopia","enrollment":144},{"nctId":"NCT05566626","phase":"NA","title":"Retinal Oxygenation Estimation Trial With Mantis Photonics Hyperspectral Camera","status":"UNKNOWN","sponsor":"Mantis Photonics AB","startDate":"2022-10","conditions":"Glaucoma Eye, Macular Degeneration, Macula Abnormality","enrollment":120},{"nctId":"NCT03201562","phase":"PHASE2","title":"A Single-Center, Double-Masked Evaluation of the Efficacy and Safety of PRX-100 in the Treatment of Early to Moderate Presbyopia","status":"COMPLETED","sponsor":"LENZ Therapeutics, Inc","startDate":"2017-04-30","conditions":"Presbyopia","enrollment":58},{"nctId":"NCT05442801","phase":"PHASE4","title":"Cycloplegic Refraction Among Children","status":"COMPLETED","sponsor":"Islamic Hospital, Jordan","startDate":"2022-03-01","conditions":"Cycloplegia","enrollment":55},{"nctId":"NCT04040790","phase":"NA","title":"Performance of Rigid Gas Permeable (RGP) Scleral Contact Lenses With a Passive Artificial Iris","status":"TERMINATED","sponsor":"University Ghent","startDate":"2019-09-16","conditions":"Low Vision","enrollment":10},{"nctId":"NCT03751631","phase":"PHASE3","title":"Safety and Efficacy of Phenylephrine 2.5%-Tropicamide 1% Microdose Ophthalmic Solution for Pupil Dilation","status":"COMPLETED","sponsor":"Eyenovia Inc.","startDate":"2018-11-15","conditions":"Mydriasis","enrollment":70},{"nctId":"NCT03751098","phase":"PHASE3","title":"Safety and Efficacy of Phenylephrine 2.5%-Tropicamide 1% Microdose Ophthalmic Solution for Pupil Dilation","status":"COMPLETED","sponsor":"Eyenovia Inc.","startDate":"2018-12-01","conditions":"Mydriasis","enrollment":76},{"nctId":"NCT04932213","phase":"PHASE3","title":"Effect of Tropicamide 0.5% vs Tropicamide 1% on Intraocular Pressure of Diabetic Patients","status":"COMPLETED","sponsor":"Semnan University of Medical Sciences","startDate":"2021-07-07","conditions":"Type 2 Diabetes Mellitus, Type 1 Diabetes Mellitus","enrollment":98},{"nctId":"NCT04880928","phase":"PHASE4","title":"Comparison Mydriasis by Mydrane With Topical Drop Application","status":"COMPLETED","sponsor":"Medical University of Graz","startDate":"2020-08-12","conditions":"Cataract","enrollment":42},{"nctId":"NCT04468022","phase":"NA","title":"Toric Trifocal IOL Treatment With High Astigmatism and Hyperopia vs SMILE Enhancement After Trifocal IOL Treatment","status":"COMPLETED","sponsor":"Eye Hospital Pristina Kosovo","startDate":"2018-06-01","conditions":"Astigmatism High Both, Pseudophakia, Hyperopia","enrollment":40},{"nctId":"NCT00748059","phase":"PHASE1","title":"The Pathophysiology of Orthostatic Hypotension","status":"COMPLETED","sponsor":"Vanderbilt University Medical Center","startDate":"1996-12","conditions":"Autonomic Nervous System Diseases, Orthostatic Hypotension, Dopamine Beta-Hydroxylase Deficiency","enrollment":10},{"nctId":"NCT04396301","phase":"PHASE3","title":"Effect of Intracameral Injection of Mydriatic Plus Anaesthetic Combination on Corneal Endothelial Count in Phaco","status":"COMPLETED","sponsor":"Cairo University","startDate":"2019-02-01","conditions":"Corneal Endothelial Cell Loss, Mydriasis, Cataract","enrollment":30},{"nctId":"NCT04117698","phase":"PHASE3","title":"Multicenter, Randomized Study Evaluating the Value of Antitubercular Treatment During Recurent Anterior Uveitis (URBA)","status":"UNKNOWN","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2019-11-01","conditions":"Uveitis, Anterior","enrollment":116},{"nctId":"NCT03139708","phase":"PHASE1","title":"The Effect of Brimonidine on Intraocular Pressure When Dilating Routine Patients","status":"COMPLETED","sponsor":"Wake Forest University Health Sciences","startDate":"2016-09","conditions":"Intraocular Pressure","enrollment":5},{"nctId":"NCT03448640","phase":"","title":"Efficacy of Mydriatic Drops in Premature Infants","status":"COMPLETED","sponsor":"Bulent Ecevit University","startDate":"2016-01-15","conditions":"Retinopathy of Prematurity","enrollment":60},{"nctId":"NCT02554396","phase":"PHASE2","title":"Evaluation of the Efficacy and Safety of PRX-100 in the Treatment of Early to Moderate Presbyopia","status":"COMPLETED","sponsor":"LENZ Therapeutics, Inc","startDate":"2015-09","conditions":"Presbyopia","enrollment":20},{"nctId":"NCT03097198","phase":"NA","title":"Effect of Plum-blossom Needle vs. Tropicamide Eye Drops on Juvenile Myopia","status":"UNKNOWN","sponsor":"Wenzhou Medical University","startDate":"2016-12","conditions":"Myopia","enrollment":98},{"nctId":"NCT02304861","phase":"NA","title":"Viscoat Versus Visthesia. A Comparative Study of Post-cataract Endothelial Cell Loss","status":"COMPLETED","sponsor":"Democritus University of Thrace","startDate":"2014-01","conditions":"Cataract","enrollment":80},{"nctId":"NCT02895074","phase":"NA","title":"Subfoveal Choroidal Thickness After Surgery for Age-related Cataracts","status":"COMPLETED","sponsor":"Sun Yat-sen University","startDate":"2014-08","conditions":"Cataract","enrollment":40},{"nctId":"NCT02101359","phase":"PHASE3","title":"Efficacy and Safety Assessment of Intracameral Injection of T2380 in Cataract Surgery","status":"COMPLETED","sponsor":"Laboratoires Thea","startDate":"2011-06","conditions":"Cataract","enrollment":609},{"nctId":"NCT01809483","phase":"PHASE3","title":"Comparison Between Bandage Contact Lens and Pressure Patching for The Erosion Area and Pain Scale in Corneal Erosion Patients","status":"COMPLETED","sponsor":"Udayana University","startDate":"2012-09","conditions":"Erosion; Cornea, Traumatic","enrollment":32},{"nctId":"NCT00877175","phase":"PHASE4","title":"Comparison of Instillation and Packing in Mydriasis for Premature Infants","status":"COMPLETED","sponsor":"Khon Kaen University","startDate":"2009-03","conditions":"Preterm Infants","enrollment":25},{"nctId":"NCT01075347","phase":"PHASE1","title":"Topical Autologous Serum Application for the Treatment of Corneal Epithelium Defect After Ocular Surgeries","status":"COMPLETED","sponsor":"National Taiwan University Hospital","startDate":"2007-03","conditions":"Corneal Epithelial Defect, Diabetic Retinopathy, Penetrating Keratoplasty","enrollment":165},{"nctId":"NCT00642135","phase":"PHASE3","title":"CLAIR -FO: Clinical Trial of Ophthalmic Insert Mydriasert® Versus Reference Treatment","status":"TERMINATED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2006-01","conditions":"Retinal Anomalies, Premature Birth","enrollment":80}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Agepha"],"phase":"marketed","status":"active","brandName":"eye drops (Tropicamid)","genericName":"eye drops (Tropicamid)","companyName":"Medical University of Graz","companyId":"medical-university-of-graz","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Tropicamide is an anticholinergic agent that blocks muscarinic acetylcholine receptors in the eye to dilate the pupil and paralyze accommodation. Used for Mydriasis and cycloplegia for diagnostic ophthalmologic examination, Pupil dilation for fundoscopic examination.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}